Trends in chronic ischemic heart disease mortality in patients with interstitial lung disease in the United States from 1999 to 2023
Chronic Respiratory Disease · 2026-04 · 23
DOI: 10.1177/14799731261446949 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chronic Respiratory Disease, online erschienen am 25.04.2026. Verfasst von Fan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Myocardial Ischemia. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Municipal Science and Technology Major Project, Shanghai Key Laboratory of Internal Medicine of Traditional Chinese Medicine, Zhang Wei’s Inheritance and Innovation Studio of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Interstitial lung disease (ILD) patients often have comorbid chronic ischemic heart disease (CIHD), which may worsen prognosis. Large-scale studies on long-term CIHD mortality trends in ILD patients are lacking. This study analyzes CIHD-related mortality trends in US adults with ILD from 1999 to 2023.
Methods
CIHD-related mortality data were extracted from the CDC WONDER database for ILD patients aged ≥25 years. International Classification of Diseases, 10th Revision (ICD-10) codes J84.1, J84.8, J84.9 identified ILD, and code I25 identified CIHD. Age-adjusted mortality rates (AAMR), annual percentage change (APC), and average annual percentage change (AAPC) per 100,000 were calculated using Joinpoint regression.
Results
Between 1999 and 2023, there were 92,779 CIHD-related deaths among U.S. decedents with interstitial lung disease (ILD, listed as an underlying or contributing cause of death in death certificates); this accounted for a substantial proportion of cardiovascular-related deaths in this decedent population. The overall AAMR showed a slight upward trend (AAPC=0.51%), but with significant nonlinearity: a decrease from 2003–2018 (APC=-1.29%), increased sharply from 2018 to 2021 (APC = 9.75%), with the increase concentrated during the COVID-19 pandemic years. The age-adjusted mortality rate rose modestly from 1.54 per 100,000 in 2018 to 1.60 in 2019 (+3.9%), then surged to 1.73 in 2020 (+8.1%) and peaked at 1.98 in 2021 (+14.5% from 2020). After 2021, mortality declined to 1.88 in 2023. Mortality was higher in men, non-Hispanic Whites, adults >85 years, and in southern and nonmetropolitan areas. Each subgroup showed a significant increase in mortality during 2020–2021, coinciding with the pandemic, while pre-pandemic trends were more gradual.
Conclusions
CIHD-related mortality in ILD patients showed a fluctuating upward trend over 25 years, with a significant jump during the COVID-19 pandemic. This underscores the systemic impact of public health emergencies on cardiovascular health in vulnerable populations. Cardiovascular risk assessment and management should be integrated into routine ILD care, with tailored strategies for high-risk groups and regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Blood Component Collection Department of Shandong, Blood Center of Shandong Province, Jinan, China.
- The First Clinical College of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Pulmonary Diseases, Shuguang Hospital, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Zhang Wei Baoshan Famous Traditional Chinese Medicine Inheritance Studio, Shanghai Baoshan Hospital of Integrated Chinese and Western Medicine, Shanghai, China.
- Institute of Infectious Diseases, Shanghai Institute of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Wei Zhang
Förderung
- Shanghai Municipal Science and Technology Major Project
- Shanghai Key Laboratory of Internal Medicine of Traditional Chinese Medicine
- Zhang Wei’s Inheritance and Innovation Studio of Traditional Chinese Medicine
- Zhang Wei Baoshan Famous Traditional Chinese Medicine Inheritance studio
- Zhang Wei Medical Technology Doctor Site Construction-Respiratory Therapy Technology Direction
Zitieren
APA
Wu, F., Xue, Y., Luan, Y., Zhang, F., Ma, X., & Zhang, W. (2026). Trends in chronic ischemic heart disease mortality in patients with interstitial lung disease in the United States from 1999 to 2023. Chronic Respiratory Disease, 23. https://doi.org/10.1177/14799731261446949
Vancouver
Wu F, Xue Y, Luan Y, Zhang F, Ma X, Zhang W. Trends in chronic ischemic heart disease mortality in patients with interstitial lung disease in the United States from 1999 to 2023. Chronic Respiratory Disease. 2026;23. doi:10.1177/14799731261446949
BibTeX
@article{Wu2026,
author = {Wu, Fan and Xue, Yan and Luan, Yinfeng and Zhang, Fengjun and Ma, Xinlai and Zhang, Wei},
title = {Trends in chronic ischemic heart disease mortality in patients with interstitial lung disease in the United States from 1999 to 2023},
journal = {Chronic Respiratory Disease},
year = {2026},
volume = {23},
doi = {10.1177/14799731261446949}
}
EUVIMED